Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Insmed Inc shares valued at $103,532 were sold by Smith Michael Alexander on Jun 03 ’25. At $71.50 per share, Smith Michael Alexander sold 1,448 shares. The insider’s holdings dropped to 69,597 shares worth approximately $5.13 million following the completion of this transaction.
Also, Flammer Martina M.D. sold 1,686 shares, netting a total of over 120,549 in proceeds. Following the sale of shares at $71.50 each, the insider now holds 83,111 shares.
Before that, Adsett Roger had sold 1,860 shares from its account. In a trade valued at $132,990, the Chief Operating Officer traded Insmed Inc shares for $71.50 each. Upon closing the transaction, the insider’s holdings decreased to 1,860 shares, worth approximately $10.41 million.
As published in their initiating research note from Jefferies on May 13, 2025, Insmed Inc [INSM] has been a Buy and the price target has been revised to $105. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of April 23, 2024, Truist has initiated its “Buy” rating for INSM. Earlier on February 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for INSM stock.
Analyzing INSM Stock Performance
During the last five days, there has been a surge of approximately 11.05%. Over the course of the year, Insmed Inc shares have jumped approximately 6.74%. Shares of the company reached a 52-week high of $84.91 on 02/21/25 and a 52-week low of $60.40 on 04/09/25.
Support And Resistance Levels for Insmed Inc (INSM)
According to the 24-hour chart, there is a support level at 73.00, which, if violated, would cause prices to drop to 72.31. In the upper region, resistance lies at 74.47. The next price resistance is at 75.25. RSI (Relative Strength Index) is 62.23 on the 14-day chart, showing neutral technical sentiment.
